The applicant sought leave to appeal an order dated January 27, 2017, which authorized the interim administration of clozapine under the Health Care Consent Act, pending an appeal from a decision of the Consent and Capacity Board.
The applicant also sought a stay of the interim treatment order if leave was granted.
The court dismissed the motion for leave to appeal, finding that the applicant failed to meet the two-part test under Rule 62.02(4) of the Rules of Civil Procedure.
Specifically, there was no conflicting decision on a matter of principle, nor was there sufficient reason to doubt the correctness of the original order.
The court also noted that the proposed appeal did not involve matters of such importance to warrant leave, particularly given the applicant's strategic decision not to accelerate the main appeal involving constitutional issues.